Press Releases

2018

November 09, 2018 Aduro Biotech Presents Preliminary Results from Ongoing Phase 1 Trials of STING agonist ADU-S100 (MIW815) in Patients with Advanced Solid Tumors or Lymphomas


November 06, 2018 Aduro to Host and Webcast an Investor Event to Review Data Presented at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting


October 30, 2018 Aduro Biotech Reports Third Quarter 2018 Financial Results


October 26, 2018 Aduro Presents Preclinical Data for Anti-APRIL Antibody BION-1301 for the Treatment of IgA Nephropathy at ASN Kidney Week 2018


October 01, 2018 Aduro Biotech Announces Four Abstracts Accepted for Presentation at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting


September 25, 2018 Aduro Biotech to Present at Two Investor Conferences in October


September 19, 2018 Aduro Biotech Announces the Departure of Natalie R. Sacks, M.D.


September 04, 2018 Aduro Biotech and Dana-Farber Cancer Institute Publish Data Highlighting Immunosuppressive Impact of APRIL in Multiple Myeloma in Leukemia


September 04, 2018 Aduro Biotech Presents Preclinical Data for BION-1301, a First-in-Class Antibody Targeting Human APRIL, at the 2018 European Congress of Immunology


August 29, 2018 Aduro Biotech to Present at the 20th Annual H.C. Wainwright Global Investment Conference


August 22, 2018 Aduro Biotech Granted Composition of Matter Patent for Novel Human APRIL Binding Antibodies


August 01, 2018 Aduro Biotech Reports Second Quarter 2018 Financial Results


June 07, 2018 Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership for ADU-214 in Combination with Nivolumab


May 10, 2018 Aduro Biotech to Present at the Bank of America Merrill Lynch 2018 Health Care Conference


May 02, 2018 Aduro Biotech Reports First Quarter 2018 Financial Results


April 26, 2018 Aduro Biotech Presents Early Observations From its Personalized Neoantigen-based pLADD Therapy Clinical Study at European Neoantigen Summit


April 17, 2018 Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting


April 02, 2018 Aduro Biotech to Present at the H.C. Wainwright Annual Global Life Sciences Conference


March 14, 2018 Aduro Biotech Announces Upcoming Data Presentations at the 2018 American Association for Cancer Research Annual Meeting


March 14, 2018 Aduro Biotech to Present at the 28th Annual Oppenheimer Healthcare Conference


March 07, 2018 Aduro Biotech to Present at the 38th Annual Cowen Healthcare Conference


March 05, 2018 Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors


March 05, 2018 Aduro Biotech Appoints Hans van Eenennaam Executive Vice President Antibody Research and Site Head, Aduro Biotech Europe


March 01, 2018 Aduro Biotech Announces Fourth Quarter and Full Year 2017 Financial Results


February 08, 2018 Aduro Biotech to Present at the Leerink Partners 7th Annual Global Healthcare Conference


January 05, 2018 Aduro Biotech Announces Management Changes


January 04, 2018 Aduro Biotech to Present at the 36th Annual J.P. Morgan Healthcare Conference